Shelton Capital Management Caribou Biosciences, Inc. Transaction History

Shelton Capital Management

  • $3.85 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$5.57 - $11.01 $67,397 - $133,221
-12,100 Reduced 7.0%
160,700 $1.01 Million
Q3 2022

Nov 14, 2022
SELL
$5.34 - $12.79 $49,128 - $117,667
-9,200 Reduced 5.05%
172,800 $1.82 Million
Q4 2021

Feb 11, 2022
BUY
$14.59 - $23.26 $641,960 - $1.02 Million
44,000 Added 31.88%
182,000 $2.75 Million
Q3 2021

Nov 15, 2021
BUY
$15.75 - $30.29 $2.17 Million - $4.18 Million
138,000 New
138,000 $3.29 Million

Others Institutions Holding CRBU

# of Institutions
135
Shares Held
52.6M
Call Options Held
148K
Put Options Held
70.7K
View Full List

About Caribou Biosciences, Inc.

CRBU Quotes by TradingView
  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $123M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email